Cevap:
Acute Lymphoblastic Leukemia Life Expectancy
The life expectancy of someone with acute lymphoblastic leukemia (ALL) varies depending on a number of factors, such as age, health history, and treatment. According to the American Cancer Society, the five-year survival rate for adults with ALL is 59%. This means that 59% of adults diagnosed with ALL will be alive five years after their diagnosis. For children, the five-year survival rate is much higher, at 90%.
For adults, the long-term outlook depends on their response to treatment and the type of ALL they have. Treatment for ALL can include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Many adults with ALL have a successful response to treatment and can go into remission, which increases their life expectancy.
For those who have a more advanced form of ALL, their life expectancy may be shorter. The average life expectancy for someone with advanced ALL is three to five years. However, there are cases of people living much longer than this, even up to 10 years or more.
Overall, the life expectancy of someone with ALL depends on many factors, including the type of ALL, the response to treatment, and the person's general health. While some people may not have a long life expectancy, with proper treatment and care, many people are able to live longer, healthier lives.